Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05174650
Title Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

intrahepatic cholangiocarcinoma


Atezolizumab + Derazantinib

Age Groups: senior | adult
Covered Countries DEU

Additional content available in CKB BOOST